RxDoctor Payments Data

Randi Hagerman, MD

Developmental - Behavioral Pediatrics · Davis, CANPI 1659356020

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $1,016 of the $1,401 with a category attached, or 72.5%. Shionogi Inc accounts for 91.9% of it on its own, with 1 other manufacturer making up the rest.

$1,401in general payments, 2019–2025

Across 32 payments — averaging $43.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Shionogi Inc$1K
  • Boston Scientific$113
$358,610in research payments, 2019–2025

Across 38 payments — averaging $9437.11 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Acadia Pharmaceuticals Inc$359K

What the payments were for

  • Travel & lodging$1,01673%
  • Food & beverage$38527%

General payments by program year

19
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Shionogi Inc30$1,289
Boston Scientific2$113

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,401 in reported general payments places this provider in the 80th percentile of 52 developmental - behavioral pediatrics providers in California.

See all developmental - behavioral pediatrics providers in California

Medicare billing

Part B allowed, 2024
$3,053
Medicare patients
15
Services billed
25

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Metformin Hcl32$4,220
Aripiprazole24$3,395
Minocycline Hcl17$1,635
Carbamazepine13$968
Metformin Hcl ErMetformin Hcl45$368
Benztropine Mesylate26$281
Risperidone13$80
Clonidine Hcl14$57
Lamotrigine12$52

Paid to pharmacies, not to this prescriber.

Other developmental - behavioral pediatrics in Davis

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →